PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,766 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹3,766 Cr |
Mar2024 | ₹4,369 Cr |
Mar2023 | ₹3,851 Cr |
Mar2022 | ₹3,118 Cr |
Mar2021 | ₹2,591 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,766 Cr | -13.80 | |
Mar2024 | ₹4,369 Cr | 13.46 | |
Mar2023 | ₹3,851 Cr | 23.51 | |
Mar2022 | ₹3,118 Cr | 20.35 | |
Mar2021 | ₹2,591 Cr | - |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,796.7 Cr | -0.4% | -2.2% | 27.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹185,609.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -0.4% |
-2.2% |
27.5% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses